2005Chinese Journal of Laboratory DiagnosisRequires access

The infection and antibiotic resistance of Pseudomonas aeruginosa

Su Qi

Open publisher page 0 citations

Abstract

Objective This study was aimed at analyzing the clinical distribution and the trend of bacterial resistance of Pseudomonas aeruginosa in our hospital. Methods we analyzed 355 strains Pseudomonas aeruginosa isolated from 2001 to 2003. The minimum inhibitory concentration(MIC) of 12 antimicrobial agents against Pseudomonas aeruginosa was examined by Walkaway40. Results was assessed according to NCCLS 2002. Results The resistance rates of Pseudomonas aeruginosa to amikacin, tobromycin, imipenem were fairly low. The resistance rates of Pseudomonas aeruginosa to ciprofloxacin, cefepime, ceftazidim, piperacillin/tazobactam, gentamicin were also low. But the resistance rates of Pseudomonas aeruginosa to other antimicrobial agents were higher than 40%. Conclusion The bacterial resistance of Pseudomonas aeruginosa is still or even a more serious clinical problem than before. It is important and urgent to monitor the bacterial resistance of Pseudomonas aeruginosa.

About this research paper

What this paper is about

Objective This study was aimed at analyzing the clinical distribution and the trend of bacterial resistance of Pseudomonas aeruginosa in our hospital. Methods we analyzed 355 strains Pseudomonas aeruginosa isolated from 2001 to 2003. The minimum inhibitory concentration(MIC) of 12 antimicrobial agents against Pseudomonas aeruginosa was examined by Walkaway40. Results was assessed according to NCCLS 2002. Results The resistance rates of Pseudomonas aeruginosa to amikacin, tobromycin, imipenem were fairly low. The resistance rates of Pseudomonas aeruginosa to ciprofloxacin, cefepime, ceftazidim, piperacillin/tazobactam, gentamicin were also low. But the resistance rates of Pseudomonas aeruginosa to other antimicrobial agents were higher than 40%. Conclusion The bacterial resistance of Pseudomonas aeruginosa is still or even a more serious clinical problem than before. It is important and urgent to monitor the bacterial resistance of Pseudomonas aeruginosa.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective This study was aimed at analyzing the clinical distribution and the trend of bacterial resistance of Pseudomonas aeruginosa in our hospital. Methods we analyzed 355 strains Pseudomonas aeruginosa isolated from 2001 to 2003. The minimum inhibitory concentration(MIC) of 12 antimicrobial agents against Pseudomonas aeruginosa was examined by Walkaway40. Results was assessed according to NCCLS 2002. Results The resistance rates of Pseudomonas aeruginosa to amikacin, tobromycin, imipenem were fairly low. The resistance rates of Pseudomonas aeruginosa to ciprofloxacin, cefepime, ceftazidim, piperacillin/tazobactam, gentamicin were also low. But the resistance rates of Pseudomonas aeruginosa to other antimicrobial agents were higher than 40%. Conclusion The bacterial resistance of Pseudomonas aeruginosa is still or even a more serious clinical problem than before. It is important and urgent to monitor the bacterial resistance of Pseudomonas aeruginosa.

Key concepts: Pseudomonas aeruginosa, Microbiology, Amikacin, Piperacillin, Cefepime, Imipenem, Antibiotic resistance, Ciprofloxacin

Related papers

Back to paper searchBrowse research topicsOriginal source
The infection and antibiotic resistance of Pseudomonas aeruginosa — Research Paper | ScholarLens